36 results about "Blood test result" patented technology

The present invention relates to in vitro prognostic method for assessing the risk of death or of liver-related event in a subject, comprising: a. obtaining at least one, preferably at least 2, of the following variables from the subject: i. biomarkers measured in a sample from the subject; ii. clinical data; iii. binary markers; iv. blood test results; b. optionally obtaining at least one blood test result by univariate combination, preferably with a binary logistic regression, of the at least one variable obtained in step (a), said blood test not being a Fibrotest, c. obtaining at least one physical data from medical imaging or clinical measurement, preferably from elastometry, more preferably from Vibration Controlled Transient Elastography (VCTE), and d. mathematically combining in a multivariate time-dependent model said at least one variable obtained in step (a) and / or said at least one blood test result obtained in step b); and said at least one physical data, obtained in step (c) thereby obtaining a prognostic score.

The present invention relates to methods and systems for providing an animal with a nutraceutical program that is specifically tailored to address the deficiencies and / or needs of the particular animal. Blood is drawn from the animal and analyzed at a lab to obtain blood test results. The blood test results are scored to obtain at least one blood test score for at least one corresponding blood parameter. If the at least one blood test score falls within a normal range but outside of an optimal range, one or more nutraceuticals needed to bring the animal within the optimal range for the at least one corresponding blood parameter are identified. A prescribed dosage amount is then calculated for at least one of the one or more identified nutraceuticals for the animal. The calculation of the prescribed dosage amount is based on at least the blood test score for the corresponding blood parameter and a deviation of the blood test score from the optimal range.

A method of evaluating gastrointestinal cancer risk. The method comprises generating a set of features comprising a plurality of current blood test results from a blood collected from a target individual, providing at least one classifier generated according to an analysis of a plurality of respective historical blood test results of each of another of a plurality of sampled individuals, and evaluating, using a processor, a gastrointestinal cancer risk of the target individual by classifying the set of features using the at least one classifier.

The present invention relates to methods and systems for providing an animal with a nutraceutical program that is specifically tailored to address the deficiencies and / or needs of the particular animal. Blood is drawn from the animal and analyzed at a lab to obtain blood test results. The blood test results are scored to obtain at least one blood test score for at least one corresponding blood parameter. If the at least one blood test score falls within a normal range but outside of an optimal range, one or more nutraceuticals needed to bring the animal within the optimal range for the at least one corresponding blood parameter are identified. A prescribed dosage amount is then calculated for at least one of the one or more identified nutraceuticals for the animal. The calculation of the prescribed dosage amount is based on at least the blood test score for the corresponding blood parameter and a deviation of the blood test score from the optimal range.

The invention discloses a device for predicting the severity of COVID-19 patients, which belongs to the intelligent processing technology of medical data. The invention includes: an input module for inputting patient information; a data preprocessing module for performing data preprocessing on the data output by the input module, if it is training data, then send the processing result to the feature selection module, if it is the data to be predicted , the processing result is sent to the prediction processing module; the feature selection module selects a certain number of features from the input features as the input feature selection result; the prediction processing module inputs the characteristic information of the patient into the preset prediction model, and The prediction results are sent to the prediction result output module for visual output. The present invention selects key features from the blood test results of patients to ensure the accuracy of prediction of severe COVID-19 patients, realizes medical assistance for rapid triage of patients with COVID-19, helps to optimize medical resources and Prompt medical intervention.

The invention provides a full-automatic blood sampling management system and method. According to the system and method, a number taking system, a main control system, a hospital LIS system, a labeling and code scanning system and a number calling system are associated to realize the interconnection of information, the medical personnel in each link can timely and correctly obtain the blood sampling item information of the patients, and the patients can conveniently know the blood sampling item information and moderately decide the approximate time of blood sampling according to the intentions, so that the problems of high manpower and material resource consumption, high operation error rate and low blood sampling process operation efficiency in the blood sampling management processes in hospitals can be solved, convenience is brought to the medical personnel or the patients to query the blood sampling item information, and the management for the blood sampling process, the blood sampling progress and the filing and query aiming at the blood test results of the patients in later period are facilitated.

The invention discloses a dual-protection vacuum blood collection tube, which comprises a tube body, an inner liner tube and a seal ring, the inner liner tube is contained in the tube body, the orifice brim of the inner liner tube is wrapped by the seal ring, moreover, the inner liner tube is elastically fastened on the inner wall of the tube body by the seal ring, a PP (polypropylene) test tube is adopted as the inner liner tube, a plastic tube is adopted as the tube body, and furthermore, the upper end of the tube body is provided with a protective gas layer. The dual-protection vacuum blood collection tube is integrated with the non-fragility of the single PET (polyethylene terephthalate) plastic tube and the waterproofness of the PP test tube, and utilizes the protective gas layer to isolate a blood sample from contacting with the air, thus ensuring the accuracy of a blood test result, the entire structure is simple, and the practicability is high.

The invention belongs to the technical field of health management. The present invention provides an evaluation method and device based on a multi-dimensional health management model. Users provide blood test results, user historical parameter information and genetic detection information corresponding to nutrients. Using the evaluation method of the present invention, evaluation can be performed from three dimensions The user's health level and blood test results can intuitively obtain the user's current nutrient status, whether it is normal, insufficient or deficient, and the user's historical parameter information and genetic information corresponding to the nutrient can obtain the user's potential nutrient deficiency or insufficient risk. Therefore, the present invention can obtain the user's nutritional status from three dimensions and multiple angles and provide health advice, such as providing vitamin supplement suggestions including but not limited to the user, so as to improve the user's nutritional status. The invention solves the technical defect of single and incomplete health management mode at present.

The invention discloses a light inspection device for detecting blood type cards, which comprises a photographing device for acquiring images of blood type cards to be detected, a rejecting device for grabbing unqualified blood type cards and rejecting them, and transporting the blood type cards through The conveying device of the photographing device, the inspection result obtained from the image processing of the blood type card, and the interaction device that controls the action of the rejecting device according to the inspection result, the interaction device is also electrically connected with the conveying device. The photographing device acquires the image of the blood type card, transmits it to the interactive device for processing, comparison and judgment, and sends an instruction to control the rejecting device to perform the rejecting action through the obtained detection result, and captures the unqualified blood type card. Realize the complete automation of blood type card detection operation, save manpower and material resources, and use more advanced intelligent detection that is not easily affected by external conditions, and the detection results are more accurate.

The invention relates to the technical field of medical devices, in particular to a blood test chip and a manufacture method thereof. The blood test chip comprises a carrier substrate, a conductive base layer arranged on the carrier substrate, and an insulating adhesive layer covering the conductive base layer, wherein a probe through hole is arranged on the insulating adhesive layer, the probe through hole is provided with a nano-metal probe protruding from the surface of the insulating adhesive layer, the nano-metal probe comprises a metal probe body and spinous protrusions on the surface of the metal probe body, antibody molecules detecting pathogens are adhered to the spinous protrusions and surroundings, the antibody molecules are at least one kind of DNA molecules, RNA molecules and immobilized enzyme molecules. Compared with the prior art, the blood test chip disclosed by the invention can give a blood test result within a few minutes or even few seconds, so that a user can know the health condition in time so as to carry out the timely disease prevention or treatment, and compared a conventional blood test in a hospital, the blood test chip greatly reduces the test cost, and makes blood test more convenient and more efficient.